For the first time in Parkinson’s disease history, three distinct therapeutic frontiers are advancing simultaneously through late-stage clinical trials. Stem cell grafts are surviving in human brains and restoring dopamine…
Three landmark breakthroughs in longevity reprogramming research 2026 are reshaping what science knows about human aging. An AI-designed drug proves itself in clinical trials, the first human epigenetic reprogramming trial…
The quiet revolution in machine‑intelligent medicine has reached critical mass. In March the U.S. Food and Drug Administration confirmed that more than one thousand medical devices incorporating artificial‑intelligence or machine‑learning…
A landmark Nature study trained an AI model on over 10 million glucose readings from healthy adults and discovered that short-term blood sugar patterns predict diabetes and cardiovascular death up…
Three landmark studies are transforming how scientists understand biological aging in 2026. From epigenetic clock data predicting mortality over 24 years, to brain training that reverses a decade of neural…
New research from 2025 reveals that structured slow breathing at five to six breaths per minute activates the vagus nerve, measurably increases heart rate variability, reduces cortisol and inflammatory biomarkers,…
Senescent “zombie” cells accumulate with age, leaking inflammatory molecules that accelerate disease across every organ. For the first time, clinical trials of senolytic drugs and CAR-T immune therapies are proving…
Three landmark developments are rewriting the rules of longevity medicine: cardiovascular prevention now starting at age 30, an AI platform published in Cell discovering treatments for liver cancer and pulmonary…
The 2026 ACC/AHA guidelines formally recognize polygenic risk scores as a risk-enhancing factor in cardiovascular prevention, marking a turning point for genomic medicine. A validated multi-ancestry score identifies up to…
Three landmark discoveries in early 2026 reveal how gut bacteria drive brain aging, epigenetic reprogramming enters its first human trial, and AI accelerates longevity science toward escape velocity.
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.